Movano

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Leabman in January 2018 and is headquartered in Pleasanton, CA.

Earnings data Q4 2022

Earnings data Q1 2023

Movano Inc. (NASDAQ:MOVE ) Q4 2022 Earnings Conference Call March 20, 2023 12:00 PM ET Company Participants J. Cogan - Chief Financial Officer John Mastrototaro - Chief Executive Officer Tyla Bucher - Chief Marketing Officer Michael Leabman - Founder and Chief Technology Officer Stacy Salvi - Vice President of Strategy Conference Call Participants Bruce Jackson - The Benchmark Company Operator Hello, and welcome to Movano Health Fourth Quarter 2022 Earnings Call.

Movano Inc. (MOVE) Q4 2022 Earnings Call Transcript

Conference call begins at 9:00 a.m. Pacific time today PLEASANTON, Calif.

Movano Health Provides Business Update and Reports Fourth Quarter 2022 Financial Results

Company developed its proprietary radio frequency technology to improve upon accuracy, cost and the size of wearable health technology PLEASANTON, Calif. , March 14, 2023 /PRNewswire/ --  Movano Health  (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, has been granted three new patents (2 US; 1 China) further safeguarding the Company's systems and methods for radio frequency-enabled health monitoring with specific protection for health parameters of blood glucose levels, blood pressure and heart rate.

Movano Health Awarded Three New Core Patents Validating its Cutting-Edge Approach to Radio Frequency-Enabled Glucose and Blood Pressure Monitoring

Movano Health's survey of 1,000 U.S. women reveals that accuracy of data is a critical feature for those considering a wearable to help them manage health. The company is eyeing an FDA clearance submission for its Evie Ring to give consumers a higher level of trust in their health data.

What Women Want: Accuracy is Critical to Future Wearable Use

PLEASANTON, Calif. , Feb. 23, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ: MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the  Evie Ring , today announced that it will report fourth quarter 2022 financial and operating results on Monday, March 20, 2023.

Movano Inc. to Report Fourth Quarter 2022 Financial Results on Monday, March 20, 2023

PLEASANTON, Calif. , Feb. 6, 2023 /PRNewswire/ -- Movano Health  (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced that it has completed a $7.5 million underwritten public offering of 5,340,600 shares of its common stock and warrants to purchase up to 2,670,300 shares of common stock, including the full exercise of the underwriter's overallotment option.

Movano Health Completes $7.5 Million Public Offering

PLEASANTON, Calif. , Jan. 27, 2023 /PRNewswire/ -- Movano Health  (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced that it has priced a $6.5 million underwritten public offering of 4,644,000 shares of its common stock and warrants to purchase up to 2,322,000 shares of common stock.

Movano Health Prices $6.5 Million Public Offering

PLEASANTON, Calif. , Jan. 26, 2023 /PRNewswire/ --  Movano Health  (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced that it is proposing to sell shares of its common stock and warrants to purchase common stock in an underwritten public offering.

Movano Health Announces Proposed Public Offering

Movano's getting a week's jump on what might well prove a banner CES for the smart ring. Today the Bay Area-based firm debuted Evie, a smart ring focused on women's health set to hit the market later next year.

Movano's new smart ring is focused on women's health

Company plans to file for FDA clearance of a new wearable that provides women with medical grade data and personalized actionable insights to track and manage overall health PLEASANTON, Calif. , Dec. 28, 2022 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices, today announces its smart ring, Evie.

Movano Health Unveils Evie: First Medical Grade Smart Ring Designed Uniquely for Women

Preliminary results demonstrated high accuracy of SpO2  and heart rate data in its pivotal hypoxia trial, bringing the Company one step closer to developing a medical device PLEASANTON, Calif. , Dec. 14, 2022 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices, today announces successful preliminary results of its pivotal hypoxia trial, which was completed in conjunction with the University of California, San Francisco (UCSF) to assess the accuracy of its smart ring's blood oxygen saturation (SpO2) and heart rate data.

Movano Health On Track to File First FDA Submission for its Smart Ring's SpO2 and Heart Rate Data Following Successful Pivotal Hypoxia Trial

The beta program is designed to advance the development of Movano Health's comprehensive health data monitoring solution WINSTON-SALEM, N.C. and PLEASANTON, Calif.

Movano Health Announces Launch of Smart Ring Beta Program with Novant Health

PLEASANTON, Calif. , Nov. 16, 2022 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices, today announced it will be participating at several upcoming investor-focused events.

Movano Health to Participate in Bernstein CGM Disruptors Conference, BTIG Digital Health Forum and Benchmark Discovery Conference

Movano Inc. (NASDAQ:MOVE ) Q3 2022 Earnings Conference Call November 14, 2022 5:00 PM ET Company Participants J. Cogan – Chief Financial Officer John Mastrototaro – Chief Executive Officer Stacy Salvi – Vice President of Strategy Conference Call Participants Marie Thibault – BTIG Operator Greetings.

Movano Inc. (MOVE) Q3 2022 Earnings Call Transcript

Conference call begins at 2:00 p.m. Pacific time today PLEASANTON, Calif.

Movano Health Provides Business Update and Reports Third Quarter 2022 Financial Results

PLEASANTON, Calif. , Nov. 1, 2022 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, today announced that it will report third quarter 2022 financial and operating results on Monday, November 14, 2022.

Movano Inc. to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022

Movano Inc. (NASDAQ:MOVE ) Q2 2022 Earnings Conference Call August 17, 2022 5:00 PM ET Company Participants John Mastrototaro - CEO J. Cogan - CFO Michael Leabman - CTO Conference Call Participants Operator Greeting and welcome to the Movano Second Quarter 2022 Earnings Call.

Movano Inc. (MOVE) CEO John Mastrototaro on Q2 2022 Results - Earnings Call Transcript

Movano Inc. Provides Business Update and Reports Second Quarter 2022 Financial Results

PLEASANTON, Calif. , Aug. 15, 2022 /PRNewswire/ -- Movano Inc. (NASDAQ: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, today announced the development of a beta testing program with Stanford Health Applied Sports Science Department.

Movano Announces Beta Program with Stanford University to Advance the Development of Comprehensive Health Data Monitoring for its Wearable Ring Solution

Former Google FitBit and Liteboxer talent join Movano as it prepares for commercialization of the Movano Ring PLEASANTON, Calif. , Aug. 11, 2022 /PRNewswire/ -- Movano Inc. (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announces today the expansion of its go-to-market leadership team with two strategic hires: Daniel Amara is joining as Vice President of User Experience (UX) and User Interface (UI) and Jim Chambers as Vice President of Digital Marketing & Growth.

Movano Expands Go-To-Market Team with Vice President of UX and UI and Vice President of Digital Marketing and Growth

PLEASANTON, Calif. , Aug. 9, 2022 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, today announced that it will report second quarter 2022 financial and operating results on Monday, August 15, 2022.

Movano to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022

Vital health metric demonstrates wearable's potential to properly track heart health and detect possible illnesses PLEASANTON, Calif. , Aug. 9, 2022 /PRNewswire/ -- Movano Inc.  (NASDAQ: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announces today the successful completion of a study with the University of California San Francisco (UCSF) to assess the accuracy of the Movano Ring's blood oxygen saturation (SpO2) and heart rate data.

Movano Ring Exceeds Accuracy Targets for SpO2 and Heart Rate Monitoring in Initial Hypoxia Study; Company Eyes FDA Submission

Movano Inc. (NASDAQ:MOVE ) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants John Mastrototaro - CEO J. Cogan - CFO Michael Leabman - CTO Conference Call Participants Michael Diana - Maxim Group Mark Argento - Lake Street Operator J.

Movano Inc. (MOVE) CEO John Mastrototaro on Q1 2022 Results - Earnings Call Transcript

Movano Inc. Provides Business Update and Reports First Quarter 2022 Financial Results

The Company was granted a new U.S. patent for the sensor's architecture that will enable accurate and cost-effective health monitoring in future medical devices PLEASANTON, Calif. , May 12, 2022 /PRNewswire/ -- Movano Inc. (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announces it has successfully validated the functionality of its proprietary and patented system-on-a-chip (SoC).

Movano Successfully Completes Functional Testing of Smallest Ever Custom mmWave Sensor Designed for Non-Invasive Glucose and Cuffless Blood Pressure Monitoring

News for Movano Stock (MOVE)